| Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents BP Bandgar, LK Adsul, HV Chavan, SS Jalde, SN Shringare, R Shaikh, ... Bioorganic & medicinal chemistry letters 22 (18), 5839-5844, 2012 | 150 | 2012 |
| PyDescriptor: A new PyMOL plugin for calculating thousands of easily understandable molecular descriptors VH Masand, V Rastija Chemometrics and Intelligent Laboratory Systems 169, 12-18, 2017 | 109 | 2017 |
| Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors YK Yoon, MA Ali, AC Wei, TS Choon, KY Khaw, V Murugaiyah, H Osman, ... Bioorganic chemistry 49, 33-39, 2013 | 86 | 2013 |
| Design, synthesis, characterization and anti-inflammatory evaluation of novel pyrazole amalgamated flavones HV Chavan, BP Bandgar, LK Adsul, VD Dhakane, PS Bhale, VN Thakare, ... Bioorganic & medicinal chemistry letters 23 (5), 1315-1321, 2013 | 60 | 2013 |
| Synthesis of α, β-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: characterization, molecular modeling, QSAR studies and … SNA Bukhari, I Jantan, VH Masand, DT Mahajan, M Sher, ... European journal of medicinal chemistry 83, 355-365, 2014 | 59 | 2014 |
| Effect of information leakage and method of splitting (rational and random) on external predictive ability and behavior of different statistical parameters of QSAR model VH Masand, DT Mahajan, GM Nazeruddin, TB Hadda, V Rastija, ... Medicinal Chemistry Research 24, 1241-1264, 2015 | 57 | 2015 |
| Tautomeric origin of dual effects of N1-nicotinoyl-3-(4′-hydroxy-3′-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines on bacterial and viral strains: POM analyses as … TB Hadda, MA Ali, V Masand, S Gharby, T Fergoug, I Warad Medicinal Chemistry Research 22, 1438-1449, 2013 | 57 | 2013 |
| Quinazoline–tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing AM Alafeefy, SI Alqasoumi, AE Ashour, V Masand, NA Al-Jaber, ... European journal of medicinal chemistry 53, 133-140, 2012 | 56 | 2012 |
| Chromones: Privileged scaffold in anticancer drug discovery VM Patil, N Masand, S Verma, V Masand Chemical Biology & Drug Design 98 (5), 943-953, 2021 | 52 | 2021 |
| CoMSIA and POM analyses of anti-malarial activity of synthetic prodiginines DT Mahajan, VH Masand, KN Patil, TB Hadda, RD Jawarkar, SD Thakur, ... Bioorganic & medicinal chemistry letters 22 (14), 4827-4835, 2012 | 48 | 2012 |
| Monte Carlo method based QSAR studies of Mer kinase inhibitors in compliance with OECD principles P Kumar, A Kumar Drug Research 68 (04), 189-195, 2018 | 44 | 2018 |
| Synthesis, molecular modeling, and biological evaluation of novel 1, 3‐diphenyl‐2‐propen‐1‐one based pyrazolines as anti‐inflammatory agents SNA Bukhari, X Zhang, I Jantan, HL Zhu, MW Amjad, VH Masand Chemical biology & drug design 85 (6), 729-742, 2015 | 42 | 2015 |
| Integrating GUSAR and QSAR analyses for antimalarial activity of synthetic prodiginines against multi drug resistant strain DT Mahajan, VH Masand, KN Patil, TB Hadda, V Rastija Medicinal chemistry research 22, 2284-2292, 2013 | 40 | 2013 |
| QSAR modeling for anti-human African trypanosomiasis activity of substituted 2-Phenylimidazopyridines VH Masand, NNE El-Sayed, DT Mahajan, AG Mercader, AM Alafeefy, ... Journal of Molecular Structure 1130, 711-718, 2017 | 36 | 2017 |
| QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CLpro Inhibitor: GA-MLR QSAR modeling supported by molecular Docking, molecular dynamics … RD Jawarkar, RL Bakal, MEA Zaki, S Al-Hussain, A Ghosh, A Gandhi, ... Arabian Journal of Chemistry 15 (1), 103499, 2022 | 33 | 2022 |
| Does tautomerism influence the outcome of QSAR modeling? VH Masand, DT Mahajan, T Ben Hadda, RD Jawarkar, AM Alafeefy, ... Medicinal chemistry research 23, 1742-1757, 2014 | 33 | 2014 |
| Molecular drug design, synthesis and pharmacophore site identification of spiroheterocyclic compounds: Trypanosoma crusi inhibiting studies T Ben Hadda, A Kerbal, B Bennani, GA Houari, M Daoudi, ACL Leite, ... Medicinal Chemistry Research 22, 57-69, 2013 | 33 | 2013 |
| QSAR study of anti-Human African Trypanosomiasis activity for 2-phenylimidazopyridines derivatives using DFT and Lipinski's descriptors S Chtita, M Ghamali, A Ousaa, A Aouidate, A Belhassan, AI Taourati, ... Heliyon 5 (3), 2019 | 32 | 2019 |
| Optimization of Antimalarial Activity of Synthetic Prodiginines: QSAR, GUSAR, and Co MFA analyses VH Masand, DT Mahajan, KN Patil, TB Hadda, MH Youssoufi, ... Chemical Biology & Drug Design 81 (4), 527-536, 2013 | 32 | 2013 |
| Identification of anti-SARS-CoV-2 compounds from food using QSAR-based virtual screening, molecular docking, and molecular dynamics simulation analysis MEA Zaki, SA Al-Hussain, VH Masand, S Akasapu, SO Bajaj, ... Pharmaceuticals 14 (4), 357, 2021 | 31 | 2021 |
Taibi BEN HADDA (Ass. Prof)Euromed University of Fez (Morocco)/ University Mohamed PremierVerified email at fso.ump.ma
